Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Chinese Patent Office
Harvard Business School
Argus Health
Colorcon
Federal Trade Commission
Merck
McKesson
Covington

Generated: July 16, 2018

DrugPatentWatch Database Preview

Details for Patent: 9,023,894

« Back to Dashboard

Title:Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
Abstract: The invention relates to a combination comprising the renin inhibitor of formula (I) ##STR00001## or a pharmaceutically acceptable salt thereof.
Inventor(s): Hewitt; William (Pottstown, PA), Vasella; Daniel L (Basel, CH), Webb; Randy L (Flemington, NJ)
Assignee: Novartis AG (Basel, CH)
Filing Date:Sep 19, 2011
Application Number:13/235,758
Claims:1. A pharmaceutical composition comprising the renin inhibitor of formula (I) ##STR00008## as a hemi-fumarate, amlodipine or a pharmaceutically acceptable salt thereof and a carrier.

2. The composition according to claim 1 for the treatment of hypertension.

3. The composition according to claim 1 for simultaneous separate or sequential use.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Daiichi Sankyo
McKinsey
Healthtrust
Express Scripts
Medtronic
Johnson and Johnson
Chinese Patent Office
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.